Liver Pathology and Alcohol • Liver Pathology and Alcohol, 1991 • Drug and Alcohol Abuse Prevention, 1990 Liver Pathology and Alcohol Edited by Ronald R. Watson University of Arizona, Tucson, Arizona Springer Science+Business Media, LLC Copyright e 1991 Springer Science+Business Media New York Originally published by Humana Presa Inc in 1991 Softcover reprint of the hardcover 1s t edition 1991 AII righls in any form whatsoever reserved. No part of this book may ba reproduced, stored in a retrieval system, or tlClllsmitted in any form or by any means (electronic, mectlanical, photocopying, microfilming, recording, or otherwise) without written permission from the publisher. Library of Congress Cataloging-in-Publication Data Liver Pathology and Alcoholledited by Ronald R. Watson. p. cm. - (Drug and alcohol abuse reviews) Includes bibliographical references and index. ISBN 978-1-4612-6755-3 ISBN 978-1-4612-0421-3 (eBook) DOI 10.1007/978-1-4612-0421-3 1. Alcoholic liver diseases. 1. Watson, Ronald R. (Ronald Ross) II. Series. [DNLM: 1. Uver--patllology. W1700 L78381] RC848.A42l581991 616.3'62--dc20 DNLMIOLC for Library of Congress 91-20879 CIP Contents viii Preface ix Contributors 1 Alcohol and Hepatic Iron Homeostasis Barry J. Potter 61 The Pathogenesis of Inflammation in Alcoholic Liver Disease F. Joseph Roll 91 Liver Cell Membrane Adaptation to Chronic Alcohol Consumption Hagai Rottenberg 117 The Effect of Prenatal Alcohol Exposure on y-Glutamyl Transpeptidase Edward Reyes 133 Free Radicals and Alcohol Liver Injury Lester A. Reinke and Paul B. McCay 169 Effects of Ethanol on Glutathione Metabolism Mack C. Mitchell, David S. Raiford, and Ariane Mallat 195 Liver Cancer: Role of Alcohol and Other Factors Siraj I. Mufti 221 Alcohol and Hepatic Protein Modification Renee C. Lin and Lawrence Lumeng v vi Contents 241 Fatty Acid Ethyl Esters, Alcohol, and Liver Changes Puran S. Bora and Louis G. Lange 259 Ethanol, Lipoprotein, Metabolism, and Fatty Liver M. R. Lakshman, Stuart J. Chirtel, and Pradeep Ghosh 287 Effect of Ethanol on Splanchnic Blood Flow Edward T. Knych 309 Interaction of Ethanol and the Glucocorticoids: Effects on Hepatic Gene Expression Rolf F. Kletzien 325 Genetic and Dietary Control of Alcohol Degradation in Drosophila: Role in Cell Damage Billy W. Geer, Robert R. Miller, Jr., and Pieter W. H. Heinstra 375 Human Liver Alcohol Dehydrogenase Gene Expression: Retinoic Acid Homeostasis and Fetal Alcohol Syndrome Gregg Duester 403 Influence of Ethanol on Functional and Biochemical Characteristics of Skeletal Muscle William E. Sonntag, Rhonda L. Boyd, Anselm D'Costa, and Charles R. Breese 425 Alcohol and Liver Damage: Xanthine Oxidase Thomas M. Soranno and Lester G. Sultatos 441 Polymorph isms of Alcohol and Aldehyde Dehydrogenases and Their Significance for Alcohol Liver Diseases Akira Yoshida and Akitaka Shibuya Contents vii 467 Effects of Alcohol and Cocaine Abuse on the Antioxidant Systems, Nutritional Status, and Liver Damage Olalekan E. Odeleye and Ronald R. Watson 513 Caffeine Metabolism:Disposition in Liver Disease and Hepatic-Function Testing Charles P. Denaro and Neal L. Benowitz 541 Marijuana, Liver Enzymes, and Toxicity Lester M. Bornheim 563 In Vivo Microscopy of the Effects of Ethanol on the Liver Robert S. McCuskey 575 Interrelationships Between the Brain and the Liver David H. Van Thiel and Ralph E. Tarter 593 Morphine and Liver Damage Louis Shuster 617 Index Preface Alcohol and other drugs of abuse are major contributing factors to liver disease and its pathology. Alcoholic cirrhosis causes thousands of deaths each year in the United States, and encourages liver replacement. A better understanding of the mechanisms of liver pathology will significantly aid basic researchers and physicians in treating and preventing liver damage. This book is designed especially for those researchers wishing to understand alcoholic liver disease. Therefore the role of alcohol in changing nutrition and its nutritional effects on liver disease are reviewed. The generation of free radicals during alcohol use has been found to be an important cause of membrane changes, of cancer development, and of lipid alterations-and thus of liver pathology. In addition to alcohol, other drugs of abuse, including morphine, cocaine, marijuana, and caffeine have also been shown to be significant contributors to liver pathology. The prevalence of drug and alcohol use and abuse today means that liver disease will continue as a major social and medical problem. The explanation of its biological origins cannot fail to help us better understand and treat the disease in the years to come. Ronald R. Watson viii Contributors Neal L. Benowitz • Department of Medicine, University of California, San Francisco, CA Puran S. Bora • Department of Medicine, Jewish Hospital of Sf. Louis at the Washington University Medical Center, Sf. Louis, MO Lester M. Bornheim • Department of Pharmacology and the Liver Center, University of California, San Francisco, CA Rhonda L. Boyd • Department of Physiology and Pharmacology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC Charles R. Breese • Department of Physiology and Pharmacology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC Stuart J. Chirtel • VA Medical Center, Washington, DC and Department of Medicine, George Washington University, Washington, DC Anselm D'Costa • Department of Physiology and Pharmacology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC Charles P. Denaro • Department of Medicine, University of California, San Francisco, CA Gregg Duester· Department of Biochemistry, Colorado State University, Fort Collins, CO Billy W. Geer • Department of Biology, Knox College, Galesburg, IL ix x Contributors Pradeep Ghosh· VA Medical Center, Washington, DC and Department of Medicine, George Washington University, Washington, DC Pieter W. H. Heinstra • Department of Biochemistry, Leiden University, Leiden, The Netherlands Rolf F. Kletzien • Department of Biological Sciences, Western Michigan University, Kalamazoo, MI Edward T. Knych • Department of Pharmacology, School of Medicine, University of Minnesota, Duluth, MN M. R. Lakshman· VA Medical Center, Washington DC and Department of Medicine, George Washington University, Washington, DC Louis G. Lange • Department of Medicine, Jewish Hospital of Sf. Louis at the Washington University Medical Center, Sf. Louis, MO Renee C. Lin • Departments of Medicine and Biochemistry, Indiana University School of Medicine, and Richard L. Roudebush VA Medical Center, Indianapolis, IN Lawrence Lumeng • Departments of Medicine and Biochemistry, Indiana University School of Medicine, and Richard L. Roudebush VA Medical Center, Indianapolis, IN Ariane Mallat • Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD Paul B. McCay· Oklahoma Medical Research Foundation, Oklahoma City, OK Robert S. McCuskey • Departments of Anatomy and Physiology, College of Medicine, University of Arizona, Tucson,)LZ Robert R. Miller, Jr. • Department of Biology, Knox College, Galesburg, IL Mack C. Mitchell • Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD
Description: